APO Research
Talk to an analyst

APO RESEARCH · REPORT

Track-and-Trace and Serialization for Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Track-and-Trace and Serialization for Drug Market Outlook and Growth Opportunities 2026

12 August 2026193 pages

Choose your research edition.

Industry ResearchTrack-and-Trace and Serialization for Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Track-and-Trace and Serialization for Drug Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Track-and-Trace and Serialization for Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Track-and-Trace and Serialization for Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Track-and-Trace and Serialization for Drug Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global Track-and-Trace and Serialization for Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Track-and-Trace and Serialization for Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Track-and-Trace and Serialization for Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Track-and-Trace and Serialization for Drug market include Bosch Packaging, SAP, Axway, Xyntec Inc, SoftGroup, TraceLink and Infosys, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Track-and-Trace and Serialization for Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Track-and-Trace and Serialization for Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Track-and-Trace and Serialization for Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Track-and-Trace and Serialization for Drug market.

Track-and-Trace and Serialization for Drug Segment by Company

Bosch Packaging

SAP

Axway

Xyntec Inc

SoftGroup

TraceLink

Infosys

Track-and-Trace and Serialization for Drug Segment by Type

Cloud-based

On-premise

Track-and-Trace and Serialization for Drug Segment by Application

Biopharmaceutical

Chemical Pharmaceutical

Track-and-Trace and Serialization for Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Track-and-Trace and Serialization for Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Track-and-Trace and Serialization for Drug key companies, revenue, market share, and recent developments.

3. To split the Track-and-Trace and Serialization for Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Track-and-Trace and Serialization for Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Track-and-Trace and Serialization for Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Track-and-Trace and Serialization for Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Track-and-Trace and Serialization for Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Track-and-Trace and Serialization for Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Track-and-Trace and Serialization for Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Track-and-Trace and Serialization for Drug industry.

Chapter 3: Detailed analysis of Track-and-Trace and Serialization for Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Track-and-Trace and Serialization for Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Track-and-Trace and Serialization for Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Track-and-Trace and Serialization for Drug Industry Trends Table 2. Track-and-Trace and Serialization for Drug Industry Drivers Table 3. Track-and-Trace and Serialization for Drug Industry Opportunities and Challenges Table 4. Track-and-Trace and Serialization for Drug Industry Restraints Table 5. Global Track-and-Trace and Serialization for Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Track-and-Trace and Serialization for Drug Revenue Share by Company (2021-2026) Table 7. Global Track-and-Trace and Serialization for Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Track-and-Trace and Serialization for Drug Key Company Manufacturing Base & Headquarters Table 9. Global Track-and-Trace and Serialization for Drug Company, Product Type & Application Table 10. Global Track-and-Trace and Serialization for Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Track-and-Trace and Serialization for Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-premise Table 16. Global Track-and-Trace and Serialization for Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Track-and-Trace and Serialization for Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Track-and-Trace and Serialization for Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Track-and-Trace and Serialization for Drug Sales Value Share by Type (2021-2026) Table 20. Global Track-and-Trace and Serialization for Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biopharmaceutical Table 22. Significant Companies of Chemical Pharmaceutical Table 23. Global Track-and-Trace and Serialization for Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Track-and-Trace and Serialization for Drug Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Track-and-Trace and Serialization for Drug Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Track-and-Trace and Serialization for Drug Sales Value Share by Application (2021-2026) Table 27. Global Track-and-Trace and Serialization for Drug Sales Value Share by Application (2027-2032) Table 28. Global Track-and-Trace and Serialization for Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Track-and-Trace and Serialization for Drug Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Track-and-Trace and Serialization for Drug Sales Value Share by Region (2021-2026) Table 31. Global Track-and-Trace and Serialization for Drug Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Track-and-Trace and Serialization for Drug Sales Value Share by Region (2027-2032) Table 33. Global Track-and-Trace and Serialization for Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Track-and-Trace and Serialization for Drug Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Track-and-Trace and Serialization for Drug Sales Value Market Share by Country (2021-2026) Table 36. Global Track-and-Trace and Serialization for Drug Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Track-and-Trace and Serialization for Drug Sales Value Market Share by Country (2027-2032) Table 38. Bosch Packaging Company Information Table 39. Bosch Packaging Business Overview Table 40. Bosch Packaging Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Bosch Packaging Track-and-Trace and Serialization for Drug Product Portfolio Table 42. Bosch Packaging Recent Development Table 43. SAP Company Information Table 44. SAP Business Overview Table 45. SAP Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. SAP Track-and-Trace and Serialization for Drug Product Portfolio Table 47. SAP Recent Development Table 48. Axway Company Information Table 49. Axway Business Overview Table 50. Axway Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Axway Track-and-Trace and Serialization for Drug Product Portfolio Table 52. Axway Recent Development Table 53. Xyntec Inc Company Information Table 54. Xyntec Inc Business Overview Table 55. Xyntec Inc Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Xyntec Inc Track-and-Trace and Serialization for Drug Product Portfolio Table 57. Xyntec Inc Recent Development Table 58. SoftGroup Company Information Table 59. SoftGroup Business Overview Table 60. SoftGroup Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. SoftGroup Track-and-Trace and Serialization for Drug Product Portfolio Table 62. SoftGroup Recent Development Table 63. TraceLink Company Information Table 64. TraceLink Business Overview Table 65. TraceLink Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. TraceLink Track-and-Trace and Serialization for Drug Product Portfolio Table 67. TraceLink Recent Development Table 68. Infosys Company Information Table 69. Infosys Business Overview Table 70. Infosys Track-and-Trace and Serialization for Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Infosys Track-and-Trace and Serialization for Drug Product Portfolio Table 72. Infosys Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Track-and-Trace and Serialization for Drug Product Image Figure 2. Global Track-and-Trace and Serialization for Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Track-and-Trace and Serialization for Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Track-and-Trace and Serialization for Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-premise Image Figure 9. Global Track-and-Trace and Serialization for Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Track-and-Trace and Serialization for Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Track-and-Trace and Serialization for Drug Sales Value Share by Type (2021-2032) Figure 12. Biopharmaceutical Image Figure 13. Chemical Pharmaceutical Image Figure 14. Global Track-and-Trace and Serialization for Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Track-and-Trace and Serialization for Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Track-and-Trace and Serialization for Drug Sales Value Share by Application (2021-2032) Figure 17. Global Track-and-Trace and Serialization for Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Track-and-Trace and Serialization for Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Track-and-Trace and Serialization for Drug Sales Value (2021-2032) & (US$ Million) Figure 20. North America Track-and-Trace and Serialization for Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Track-and-Trace and Serialization for Drug Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Track-and-Trace and Serialization for Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Track-and-Trace and Serialization for Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Track-and-Trace and Serialization for Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Track-and-Trace and Serialization for Drug Sales Value (2021-2032) & (US$ Million) Figure 26. South America Track-and-Trace and Serialization for Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Track-and-Trace and Serialization for Drug Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Track-and-Trace and Serialization for Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Biopharmaceutical
  • Chemical Pharmaceutical
Companies covered
  • Bosch Packaging
  • SAP
  • Axway
  • Xyntec Inc
  • SoftGroup
  • TraceLink
  • Infosys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Track-and-Trace and Serialization for Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Track-and-Trace and Serialization for Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Track-and-Trace and Serialization for Drug Market Dynamics
  1. 2.1 Track-and-Trace and Serialization for Drug Industry Trends
  2. 2.2 Track-and-Trace and Serialization for Drug Industry Drivers
  3. 2.3 Track-and-Trace and Serialization for Drug Industry Opportunities and Challenges
  4. 2.4 Track-and-Trace and Serialization for Drug Industry Restraints
3 Track-and-Trace and Serialization for Drug Market by Company
  1. 3.1 Global Track-and-Trace and Serialization for Drug Company Revenue Ranking in 2025
  2. 3.2 Global Track-and-Trace and Serialization for Drug Revenue by Company (2021-2026)
  3. 3.3 Global Track-and-Trace and Serialization for Drug Company Ranking (2024-2026)
  4. 3.4 Global Track-and-Trace and Serialization for Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Track-and-Trace and Serialization for Drug Company Product Type and Application
  6. 3.6 Global Track-and-Trace and Serialization for Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Track-and-Trace and Serialization for Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Track-and-Trace and Serialization for Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Track-and-Trace and Serialization for Drug Market by Type
  1. 4.1 Track-and-Trace and Serialization for Drug Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-premise
  4. 4.2 Global Track-and-Trace and Serialization for Drug Sales Value by Type
  5. 4.2.1 Global Track-and-Trace and Serialization for Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Track-and-Trace and Serialization for Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Track-and-Trace and Serialization for Drug Sales Value Share by Type (2021-2032)
5 Track-and-Trace and Serialization for Drug Market by Application
  1. 5.1 Track-and-Trace and Serialization for Drug Application Introduction
  2. 5.1.1 Biopharmaceutical
  3. 5.1.2 Chemical Pharmaceutical
  4. 5.2 Global Track-and-Trace and Serialization for Drug Sales Value by Application
  5. 5.2.1 Global Track-and-Trace and Serialization for Drug Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Track-and-Trace and Serialization for Drug Sales Value by Application (2021-2032)
  7. 5.2.3 Global Track-and-Trace and Serialization for Drug Sales Value Share by Application (2021-2032)
6 Track-and-Trace and Serialization for Drug Regional Value Analysis
  1. 6.1 Global Track-and-Trace and Serialization for Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Track-and-Trace and Serialization for Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Track-and-Trace and Serialization for Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Track-and-Trace and Serialization for Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Track-and-Trace and Serialization for Drug Sales Value (2021-2032)
  7. 6.3.2 North America Track-and-Trace and Serialization for Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Track-and-Trace and Serialization for Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Track-and-Trace and Serialization for Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Track-and-Trace and Serialization for Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Track-and-Trace and Serialization for Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Track-and-Trace and Serialization for Drug Sales Value (2021-2032)
  16. 6.6.2 South America Track-and-Trace and Serialization for Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Track-and-Trace and Serialization for Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Track-and-Trace and Serialization for Drug Sales Value Share by Country, 2025 VS 2032
7 Track-and-Trace and Serialization for Drug Country-level Value Analysis
  1. 7.1 Global Track-and-Trace and Serialization for Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Track-and-Trace and Serialization for Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Track-and-Trace and Serialization for Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Track-and-Trace and Serialization for Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Track-and-Trace and Serialization for Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Track-and-Trace and Serialization for Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Track-and-Trace and Serialization for Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bosch Packaging
  2. 8.1.1 Bosch Packaging Company Information
  3. 8.1.2 Bosch Packaging Business Overview
  4. 8.1.3 Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bosch Packaging Track-and-Trace and Serialization for Drug Product Portfolio
  6. 8.1.5 Bosch Packaging Recent Developments
  7. 8.2 SAP
  8. 8.2.1 SAP Company Information
  9. 8.2.2 SAP Business Overview
  10. 8.2.3 SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SAP Track-and-Trace and Serialization for Drug Product Portfolio
  12. 8.2.5 SAP Recent Developments
  13. 8.3 Axway
  14. 8.3.1 Axway Company Information
  15. 8.3.2 Axway Business Overview
  16. 8.3.3 Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Axway Track-and-Trace and Serialization for Drug Product Portfolio
  18. 8.3.5 Axway Recent Developments
  19. 8.4 Xyntec Inc
  20. 8.4.1 Xyntec Inc Company Information
  21. 8.4.2 Xyntec Inc Business Overview
  22. 8.4.3 Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Xyntec Inc Track-and-Trace and Serialization for Drug Product Portfolio
  24. 8.4.5 Xyntec Inc Recent Developments
  25. 8.5 SoftGroup
  26. 8.5.1 SoftGroup Company Information
  27. 8.5.2 SoftGroup Business Overview
  28. 8.5.3 SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SoftGroup Track-and-Trace and Serialization for Drug Product Portfolio
  30. 8.5.5 SoftGroup Recent Developments
  31. 8.6 TraceLink
  32. 8.6.1 TraceLink Company Information
  33. 8.6.2 TraceLink Business Overview
  34. 8.6.3 TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 TraceLink Track-and-Trace and Serialization for Drug Product Portfolio
  36. 8.6.5 TraceLink Recent Developments
  37. 8.7 Infosys
  38. 8.7.1 Infosys Company Information
  39. 8.7.2 Infosys Business Overview
  40. 8.7.3 Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Infosys Track-and-Trace and Serialization for Drug Product Portfolio
  42. 8.7.5 Infosys Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst